(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6.67%152.58B | 3.13%90.04B | -0.60%32.18B | 5.08%234.26B | 5.51%143.04B | 7.39%87.3B | 5.65%32.38B | -1.24%222.94B | -6.16%135.56B | -14.84%81.3B |
Operating income | 6.67%152.58B | 3.13%90.04B | -0.60%32.18B | 5.08%234.26B | 5.51%143.04B | 7.39%87.3B | 5.65%32.38B | -1.24%222.94B | -6.16%135.56B | -14.84%81.3B |
Operating expenses | -5.46%-120.21B | -0.62%-70.76B | 4.92%-24.16B | -3.69%-182.1B | -5.87%-113.99B | -8.31%-70.33B | -4.45%-25.41B | 2.05%-175.63B | 5.45%-107.67B | 13.87%-64.93B |
Gross profit | 11.44%32.37B | 13.57%19.27B | 15.15%8.02B | 10.25%52.16B | 4.12%29.04B | 3.72%16.97B | 10.27%6.96B | 1.91%47.31B | -8.81%27.9B | -18.48%16.36B |
Selling expenses | -4.91%-3.43B | -2.87%-2.13B | -15.10%-1.49B | -18.91%-9.18B | 23.56%-3.27B | 18.61%-2.07B | -15.98%-1.29B | -6.33%-7.72B | 18.16%-4.28B | 22.24%-2.54B |
Administrative expenses | -3.90%-9.47B | -4.96%-5.83B | -8.83%-2.81B | -4.16%-13.96B | -8.10%-9.11B | -6.15%-5.56B | -0.22%-2.58B | 0.59%-13.4B | 6.85%-8.43B | 11.88%-5.24B |
Research and development expenses | -21.61%-9.7B | -20.94%-5.79B | -17.46%-2.44B | -9.40%-14.36B | -6.47%-7.98B | -5.85%-4.79B | -10.41%-2.08B | -0.34%-13.13B | 0.85%-7.49B | 11.01%-4.53B |
Profit from asset sales | -79.62%54.8M | -90.75%25.02M | 30.25%17.93M | -83.99%408.46M | -65.05%268.88M | -50.76%270.52M | 738.31%13.77M | 150.99%2.55B | 24.28%769.25M | 9.23%549.36M |
Revaluation surplus | -13.30%261.16M | 10.91%257.95M | -13.12%106.7M | -19.96%392.04M | -30.83%301.21M | -15.81%232.57M | 3.24%122.82M | 58.04%489.77M | 290.89%435.48M | 261.07%276.24M |
-Changes in the fair value of other assets | -13.30%261.16M | 10.91%257.95M | -13.12%106.7M | -19.96%392.04M | -30.83%301.21M | -15.81%232.57M | 3.24%122.82M | 58.04%489.77M | 290.89%435.48M | 261.07%276.24M |
Impairment and provision | -30.63%-722.06M | 20.88%-365.23M | -47.53%-51.02M | -101.71%-1.87B | -0.70%-552.77M | -55.30%-461.63M | 10.51%-34.58M | 0.08%-926.44M | -10.18%-548.92M | 33.59%-297.25M |
-Other impairment is provision | -30.63%-722.06M | 20.88%-365.23M | -47.53%-51.02M | -101.71%-1.87B | -0.70%-552.77M | -55.30%-461.63M | 10.51%-34.58M | 0.08%-926.44M | -10.18%-548.92M | 33.59%-297.25M |
Special items of operating profit | 90.85%2.7B | 90.86%1.78B | 57.75%814.64M | 87.50%3.94B | 27.81%1.42B | 62.30%934.62M | 118.09%516.4M | 10.45%2.1B | -8.40%1.11B | -23.85%575.85M |
Operating profit | 20.37%10.91B | 33.06%6.46B | 35.79%1.85B | 1.13%15.81B | 7.36%9.06B | 7.73%4.86B | 71.27%1.37B | 18.36%15.64B | -7.89%8.44B | -24.57%4.51B |
Financing cost | -391.34%-136.6M | -97.91%7.91M | 138.66%54.07M | -38.19%212.3M | -85.35%46.89M | 201.90%377.78M | -157.75%-139.87M | 190.35%343.49M | 162.63%320.13M | 137.82%125.14M |
Special items of earning before tax | 43.30%262.81M | 44.99%146.56M | -28.50%64.91M | 148.09%347.24M | -42.65%183.41M | -52.59%101.08M | -5.49%90.78M | -84.85%139.97M | -29.71%319.78M | -18.09%213.19M |
Earning before tax | 18.74%11.03B | 24.01%6.62B | 49.89%1.97B | 1.57%16.37B | 2.33%9.29B | 10.09%5.34B | 56.89%1.32B | 17.19%16.12B | -0.30%9.08B | -17.94%4.85B |
Tax | -22.92%-1.56B | -38.96%-1.11B | -67.33%-454.24M | -2.03%-1.8B | 4.68%-1.27B | -3.49%-796.68M | 6.22%-271.47M | -32.17%-1.77B | -0.64%-1.33B | 26.61%-769.84M |
After-tax profit from continuing operations | 18.08%9.47B | 21.39%5.51B | 45.36%1.52B | 1.52%14.57B | 3.53%8.02B | 11.34%4.54B | 90.14%1.05B | 15.58%14.35B | -0.46%7.75B | -16.06%4.08B |
Earning after tax | 18.08%9.47B | 21.39%5.51B | 45.36%1.52B | 1.52%14.57B | 3.53%8.02B | 11.34%4.54B | 90.14%1.05B | 15.58%14.35B | -0.46%7.75B | -16.06%4.08B |
Minority profit | 19.10%2.23B | 21.36%1.31B | 18.88%510.96M | 5.90%2.86B | 8.69%1.87B | 14.03%1.08B | 30.27%429.82M | 27.60%2.7B | 30.10%1.72B | 8.91%947.18M |
Profit attributable to shareholders | 17.77%7.24B | 21.40%4.2B | 63.86%1.01B | 0.50%11.71B | 2.06%6.15B | 10.53%3.46B | 180.01%615.33M | 13.11%11.65B | -6.71%6.03B | -21.51%3.13B |
Basic earnings per share | 19.05%0.25 | 25.00%0.15 | 100.00%0.04 | 0.00%0.41 | 0.00%0.21 | 9.09%0.12 | 100.00%0.02 | 13.89%0.41 | -8.70%0.21 | -21.43%0.11 |
Diluted earnings per share | 19.05%0.25 | 25.00%0.15 | 100.00%0.04 | 0.00%0.41 | 0.00%0.21 | 9.09%0.12 | 100.00%0.02 | 13.89%0.41 | -8.70%0.21 | -21.43%0.11 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data